ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

NCI Advisors Approve New Grant Program In Bone Metastasis

April 5, 2002

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010

How Construction Grantees Will Spend Their $30 Million

September 12, 1975

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011

In Brief: Magnuson Subcommittee Increases NCI, NIH Budgets Despite Trimming Labor-HEW Bill By $250 Million

August 23, 1974